Literature DB >> 20005283

Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient diet.

Jia-Min Zhuo1, Domenico Praticò.   

Abstract

Epidemiological and clinical studies indicate that elevated circulating level of homocysteine (Hcy) is a risk factor for developing Alzheimer's disease (AD). Dietary deficiency of folate, vitamin B6 and B12 results in a significant increase of Hcy levels, a condition also known as hyperhomocysteinemia (HHcy). In the present study we tested the hypothesis that a diet deficient for these three important factors when administered to a mouse model of AD, i.e. Tg2576, will result in HHcy and in an acceleration of their amylodotic phenotype. Compared with Tg2576 mice on regular chow, the ones receiving the diet deficient for folate, B6 and B12 developed HHcy. This condition was associated with a significant increase in Abeta levels in the cortex and hippocampus, and an elevation of Abeta deposits in the same regions. No significant changes were observed for steady-state levels of total APP, BACE-1, ADAM-10, PS1 and nicastrin in the brains of mice with HHcy. No differences were observed for the main Abeta catabolic pathways, i.e. IDE and neprilysin proteins, or the Abeta chaperone apolipoprotein E. Our findings demonstrate that a dietary condition which leads to HHcy may also result in increased Abeta levels and deposition in a transgenic mouse model of AD-like amylodosis. They further support the concept that dietary factors can contribute to the development of AD neuropathology. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20005283      PMCID: PMC2826592          DOI: 10.1016/j.exger.2009.12.005

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  51 in total

Review 1.  Hyperhomocysteinemia and oxidative stress: time for a reality check?

Authors:  D W Jacobsen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

2.  Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.

Authors:  M A Chishti; D S Yang; C Janus; A L Phinney; P Horne; J Pearson; R Strome; N Zuker; J Loukides; J French; S Turner; G Lozza; M Grilli; S Kunicki; C Morissette; J Paquette; F Gervais; C Bergeron; P E Fraser; G A Carlson; P S George-Hyslop; D Westaway
Journal:  J Biol Chem       Date:  2001-03-15       Impact factor: 5.157

3.  Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Authors:  Sudha Seshadri; Alexa Beiser; Jacob Selhub; Paul F Jacques; Irwin H Rosenberg; Ralph B D'Agostino; Peter W F Wilson; Philip A Wolf
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

4.  Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease.

Authors:  Inna I Kruman; T S Kumaravel; Althaf Lohani; Ward A Pedersen; Roy G Cutler; Yuri Kruman; Norman Haughey; Jaewon Lee; Michele Evans; Mark P Mattson
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

5.  Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.

Authors:  D Praticò; K Uryu; S Leight; J Q Trojanoswki; V M Lee
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

6.  A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Authors:  L M Refolo; M A Pappolla; J LaFrancois; B Malester; S D Schmidt; T Thomas-Bryant; G S Tint; R Wang; M Mercken; S S Petanceska; K E Duff
Journal:  Neurobiol Dis       Date:  2001-10       Impact factor: 5.996

7.  Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model.

Authors:  M A Hofmann; E Lalla; Y Lu; M R Gleason; B M Wolf; N Tanji; L J Ferran; B Kohl; V Rao; W Kisiel; D M Stern; A M Schmidt
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

8.  Hyperhomocysteinemia in dementia.

Authors:  F Leblhuber; J Walli; E Artner-Dworzak; K Vrecko; B Widner; G Reibnegger; D Fuchs
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

9.  Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme a reductase in vascular endothelial cells: a mechanism for development of atherosclerosis?

Authors:  Hong Li; Avalyn Lewis; Sergey Brodsky; Robert Rieger; Charles Iden; Michael S Goligorsky
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

10.  Changes in Presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency.

Authors:  Andrea Fuso; Vincenzina Nicolia; Alessia Pasqualato; Maria Teresa Fiorenza; Rosaria A Cavallaro; Sigfrido Scarpa
Journal:  Neurobiol Aging       Date:  2009-03-28       Impact factor: 4.673

View more
  31 in total

1.  The involvement of homocysteine in stress-induced Aβ precursor protein misprocessing and related cognitive decline in rats.

Authors:  Fang Xie; Yun Zhao; Jing Ma; Jing-Bo Gong; Shi-Da Wang; Liang Zhang; Xiu-Jie Gao; Ling-Jia Qian
Journal:  Cell Stress Chaperones       Date:  2016-07-19       Impact factor: 3.667

2.  Transcriptional regulation of β-secretase-1 by 12/15-lipoxygenase results in enhanced amyloidogenesis and cognitive impairments.

Authors:  Jin Chu; Jia-Min Zhuo; Domenico Praticò
Journal:  Ann Neurol       Date:  2012-01       Impact factor: 10.422

Review 3.  Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research.

Authors:  Richard S Beard; Shawn E Bearden
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

Review 4.  Diet, cognition, and Alzheimer's disease: food for thought.

Authors:  Ane Otaegui-Arrazola; Pilar Amiano; Ana Elbusto; Elena Urdaneta; Pablo Martínez-Lage
Journal:  Eur J Nutr       Date:  2013-07-27       Impact factor: 5.614

Review 5.  Age-related lysosomal dysfunction: an unrecognized roadblock for cobalamin trafficking?

Authors:  Hua Zhao; Ulf T Brunk; Brett Garner
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

Review 6.  Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

Authors:  Jia-Min Zhuo; Hong Wang; Domenico Praticò
Journal:  Trends Pharmacol Sci       Date:  2011-06-20       Impact factor: 14.819

Review 7.  Is Alzheimer's Disease Risk Modifiable?

Authors:  Alberto Serrano-Pozo; John H Growdon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

8.  Excess folate during adolescence suppresses thyroid function with permanent deficits in motivation and spatial memory.

Authors:  L J Sittig; L B K Herzing; H Xie; K K Batra; P K Shukla; E E Redei
Journal:  Genes Brain Behav       Date:  2011-12-13       Impact factor: 3.449

9.  Early Manifestations of Brain Aging in Mice Due to Low Dietary Folate and Mild MTHFR Deficiency.

Authors:  Renata H Bahous; Marta Cosín-Tomás; Liyuan Deng; Daniel Leclerc; Olga Malysheva; Ming-Kai Ho; Mercè Pallàs; Perla Kaliman; Barry J Bedell; Marie A Caudill; Rima Rozen
Journal:  Mol Neurobiol       Date:  2018-10-04       Impact factor: 5.590

10.  Gene-environment interaction research and transgenic mouse models of Alzheimer's disease.

Authors:  L Chouliaras; A S R Sierksma; G Kenis; J Prickaerts; M A M Lemmens; I Brasnjevic; E L van Donkelaar; P Martinez-Martinez; M Losen; M H De Baets; N Kholod; F van Leeuwen; P R Hof; J van Os; H W M Steinbusch; D L A van den Hove; B P F Rutten
Journal:  Int J Alzheimers Dis       Date:  2010-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.